TAEK-VAC-HerBy vaccine (Bavarian Nordic)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameTAEK-VAC-HerBy vaccine (Bavarian Nordic)
Drug Alias NameHER2- expressing cancer vaccine (Bavarian Nordic)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsGastroesophageal Junction NeoplasmsHR-positive breast cancerStomach Neoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBavarian Nordic A/S
China Registration ClassN/A

Develop Information

Active CompaniesBavarian Nordic A/S
Inactive CompaniesN/A
Active IndicationsGastroesophageal Junction NeoplasmsHR-positive breast cancerStomach Neoplasms +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A